Andrew D Hahn1, Jeff Kammerman1, Sean B Fain1,2,3. 1. Department of Medical Physics, University of Wisconsin, Madison, Wisconsin. 2. Department of Radiology, University of Wisconsin, Madison, Wisconsin. 3. Department of Biomedical Engineering, University of Wisconsin, Madison, Wisconsin.
Abstract
PURPOSE: A novel technique is presented for retrospective estimation and removal of gas-phase hyperpolarized Xenon-129 (HP 129 Xe) from images of HP 129 Xe dissolved in the barrier (comprised of parenchymal lung tissue and blood plasma) and red blood cell (RBC) phases. The primary aim is mitigating RF pulse performance limitations on measures of gas exchange (e.g., barrier-gas and RBC-gas ratios). Correction for gas contamination would simplify technical dissemination of HP 129 Xe applications across sites with varying hardware performance, scanner vendors, and models. METHODS: Digital lung phantom and human subject experiments (N = 8 healthy; N = 1 with idiopathic pulmonary fibrosis) were acquired with 3D radial trajectory and 1-point Dixon spectroscopic imaging to assess the correction method for mitigating barrier and RBC imaging artifacts. Dependence of performance on TE, image SNR, and gas contamination level were characterized. Inter- and intra-subject variation in the dissolved-phase ratios were quantified and compared to human subject experiments before and after correction. RESULTS: Gas contamination resulted in image artifacts similar to those in disease that were mitigated after correction in both simulated and human subject data; for simulation experiments performance varied with TE, but was independent of image SNR and the amount of gas contamination. Artifacts and variation of barrier and RBC components were reduced after correction in both simulation and healthy human lungs (barrier, P = 0.01; RBC, P = 0.045). CONCLUSION: The proposed technique significantly reduced regional variations in barrier and RBC ratios, separated using a 1-point Dixon approach, with improved accuracy of dissolved-phase HP 129 Xe images confirmed in simulation experiments.
PURPOSE: A novel technique is presented for retrospective estimation and removal of gas-phase hyperpolarized Xenon-129 (HP 129 Xe) from images of HP 129 Xe dissolved in the barrier (comprised of parenchymal lung tissue and blood plasma) and red blood cell (RBC) phases. The primary aim is mitigating RF pulse performance limitations on measures of gas exchange (e.g., barrier-gas and RBC-gas ratios). Correction for gas contamination would simplify technical dissemination of HP 129 Xe applications across sites with varying hardware performance, scanner vendors, and models. METHODS: Digital lung phantom and human subject experiments (N = 8 healthy; N = 1 with idiopathic pulmonary fibrosis) were acquired with 3D radial trajectory and 1-point Dixon spectroscopic imaging to assess the correction method for mitigating barrier and RBC imaging artifacts. Dependence of performance on TE, image SNR, and gas contamination level were characterized. Inter- and intra-subject variation in the dissolved-phase ratios were quantified and compared to human subject experiments before and after correction. RESULTS:Gas contamination resulted in image artifacts similar to those in disease that were mitigated after correction in both simulated and human subject data; for simulation experiments performance varied with TE, but was independent of image SNR and the amount of gas contamination. Artifacts and variation of barrier and RBC components were reduced after correction in both simulation and healthy human lungs (barrier, P = 0.01; RBC, P = 0.045). CONCLUSION: The proposed technique significantly reduced regional variations in barrier and RBC ratios, separated using a 1-point Dixon approach, with improved accuracy of dissolved-phase HP 129 Xe images confirmed in simulation experiments.
Authors: Xiaojun Xu; Graham Norquay; Steven R Parnell; Martin H Deppe; Salma Ajraoui; Ralph Hashoian; Helen Marshall; Paul D Griffiths; Juan Parra-Robles; Jim M Wild Journal: Magn Reson Med Date: 2012-01-31 Impact factor: 4.668
Authors: Lukas Ebner; Jeff Kammerman; Bastiaan Driehuys; Mark L Schiebler; Robert V Cadman; Sean B Fain Journal: Eur J Radiol Date: 2016-09-16 Impact factor: 3.528
Authors: Iga Muradyan; James P Butler; Mikayel Dabaghyan; Mirko Hrovat; Isabel Dregely; Iulian Ruset; George P Topulos; Eric Frederick; Hiroto Hatabu; William F Hersman; Samuel Patz Journal: J Magn Reson Imaging Date: 2012-09-25 Impact factor: 4.813
Authors: Ziyi Wang; Scott Haile Robertson; Jennifer Wang; Mu He; Rohan S Virgincar; Geoffry M Schrank; Elianna A Bier; Sudarshan Rajagopal; Yuh Chin Huang; Thomas G O'Riordan; Craig R Rackley; H Page McAdams; Bastiaan Driehuys Journal: Med Phys Date: 2017-05-18 Impact factor: 4.071
Authors: Zackary I Cleveland; Gary P Cofer; Gregory Metz; Denise Beaver; John Nouls; S Sivaram Kaushik; Monica Kraft; Jan Wolber; Kevin T Kelly; H Page McAdams; Bastiaan Driehuys Journal: PLoS One Date: 2010-08-16 Impact factor: 3.240
Authors: Andrew D Hahn; Jeff Kammerman; Michael Evans; Wei Zha; Robert V Cadman; Keith Meyer; Nathan Sandbo; Sean B Fain Journal: J Magn Reson Imaging Date: 2019-04-10 Impact factor: 4.813
Authors: Peter J Niedbalski; Junlan Lu; Chase S Hall; Mario Castro; John P Mugler; Yun M Shim; Bastiaan Driehuys Journal: Magn Reson Med Date: 2021-10-13 Impact factor: 4.668
Authors: Matthew M Willmering; Laura L Walkup; Peter J Niedbalski; Hui Wang; Ziyi Wang; Erik B Hysinger; Kasiani C Myers; Christopher T Towe; Bastiaan Driehuys; Zackary I Cleveland; Jason C Woods Journal: J Magn Reson Imaging Date: 2022-03-04 Impact factor: 5.119
Authors: Peter J Niedbalski; Alexander S Cochran; Teckla G Akinyi; Robert P Thomen; Elizabeth M Fugate; Diana M Lindquist; Ronald G Pratt; Zackary I Cleveland Journal: NMR Biomed Date: 2020-04-14 Impact factor: 4.044
Authors: Leith J Rankine; Ziyi Wang; Chris R Kelsey; Elianna Bier; Bastiaan Driehuys; Lawrence B Marks; Shiva K Das Journal: Int J Radiat Oncol Biol Phys Date: 2021-07-13 Impact factor: 7.038